[go: up one dir, main page]

MX9802284A - Antigenos de leishmania para usarse en la terapia y diagnostico de leishmaniasis. - Google Patents

Antigenos de leishmania para usarse en la terapia y diagnostico de leishmaniasis.

Info

Publication number
MX9802284A
MX9802284A MX9802284A MX9802284A MX9802284A MX 9802284 A MX9802284 A MX 9802284A MX 9802284 A MX9802284 A MX 9802284A MX 9802284 A MX9802284 A MX 9802284A MX 9802284 A MX9802284 A MX 9802284A
Authority
MX
Mexico
Prior art keywords
leishmaniasis
therapy
diagnosis
leishmania antigens
leishmania
Prior art date
Application number
MX9802284A
Other languages
English (en)
Other versions
MXPA98002284A (es
Inventor
Steven G Reed
Antonio Campos-Neto
John R Webb
Davin C Dillon
Yasir A Skeiky
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of MX9802284A publication Critical patent/MX9802284A/es
Publication of MXPA98002284A publication Critical patent/MXPA98002284A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Se describen composiciones y métodos para prevenir, tratar y detectar leishmaniasis y para estimular respuestas inmunes en pacientes. Los compuestos provistos incluyen polipéptidos que contienen, por lo menos, una porcion inmunogénica de uno o más antígenos de Leishmania, o una variante de los mismos. También se proveen vacunas y composiciones farmacéuticas que comprenden dichos polipéptidos y pueden ser utilizadas por ejemplo, para la prevencion y terapia de leishmaniasis, así como para la deteccion de infeccion por Leishmania.
MXPA/A/1998/002284A 1995-09-22 1998-03-23 Antigenos de leishmania para usarse en la terapia y diagnostico de leishmaniasis MXPA98002284A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/533,669 US5834592A (en) 1995-09-22 1995-09-22 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US08533669 1995-09-22

Publications (2)

Publication Number Publication Date
MX9802284A true MX9802284A (es) 1998-08-30
MXPA98002284A MXPA98002284A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
BRPI9610679B1 (pt) 2017-05-16
EP0854924A1 (en) 1998-07-29
PT854924E (pt) 2003-11-28
EP0854924B1 (en) 2003-06-25
DE69628844D1 (de) 2003-07-31
US5834592A (en) 1998-11-10
DE69628844T2 (de) 2004-05-19
BR9610679A (pt) 1999-03-30
ATE243750T1 (de) 2003-07-15
AU7242796A (en) 1997-04-09
US6709661B1 (en) 2004-03-23
ES2205059T3 (es) 2004-05-01
WO1997011180A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
AU7242796A (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ZA898833B (en) Skin test and test kit for aids
AU2210899A (en) Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
CY2570B1 (en) Compounds for immunotherapy and diagnosis of tuberculosis
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
EP2172551A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
MXPA02010173A (es) Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.
GR3031250T3 (en) Methods of diagnosing and treating preeclampsia
IL97709A0 (en) Peptides and pharmaceutical compositions for treating multiple sclerosis containing the same
WO1998035045A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
WO2002098359A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
HUT56286A (en) Vaccine against swine cholera and diagnostic examination
EP1422238A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
AU5061090A (en) Aids therapy
EP0342416A3 (en) Medicine
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
OA08626A (en) Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections.
FR2679909B1 (fr) Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.
AU4123297A (en) Alkaloid glycoside for use as a medicament
UA36246A (uk) Спосіб діагностики і препарування прихованих каріозних уражень апроксимальних поверхонь молярів нижче екватору
GR3020723T3 (en) Hog cholera virus vaccine and diagnostic.
IT8919574A0 (it) Procedimento ed impianto per la preparazione di prodotti farmaceutici in genere.